Author

Shipra Gandhi

Assistant Professor of Oncology, Roswell Park Comprehensive Cancer Center - Cited by 636 - breast cancer

Biography

Dr. Shipra Gandhi works in the Department of Internal Medicine, University at Buffalo, NY, USA, is a well known researher and one of his famous works are Surgery for Isolated Metachronous Thyroid Metastasis in a Non-small Cell Lung Carcinoma Patient with Hashimoto’s Thyroiditis: A Case Report
Title
Cited by
Year
NR2F1, a tumor dormancy marker, is expressed predominantly in cancer-associated fibroblasts and is associated with suppressed breast cancer cell proliferation
R Wu, AM Roy, Y Tokumaru, S Gandhi, M Asaoka, M Oshi, L Yan, ...Cancers 14 (12), 262, 2022202
9
2022
Development of a novel BRCAness score that predicts response to PARP inhibitors
M Oshi, S Gandhi, R Wu, M Asaoka, L Yan, A Yamada, S Yamamoto, ...Biomarker Research 10 (1), 1-11, 2022202
7
2022
Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer
M Oshi, S Gandhi, L Yan, Y Tokumaru, R Wu, A Yamada, R Matsuyama, ...Breast Cancer Research and Treatment 194 (2), 231-241, 2022202
7
2022
Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?
RK Gupta, AM Roy, A Gupta, K Takabe, A Dhakal, M Opyrchal, P Kalinski, ...Cancers 14 (8), 1856, 2022202
7
2022
Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
Y Abdou, M Gupta, M Asaoka, K Attwood, O Mateusz, S Gandhi, K TakabeScientific Reports 12 (1), 13377, 2022202
6
2022
Clinical outcomes of ovarian cancer patients treated with the novel engineered cytokine nemvaleukin alfa in combination with the PD-1 inhibitor pembrolizumab: recent data from …
I Winer, U Vaishampayan, L Gilbert, S Rosen, S Gandhi, Y Wang, Y Du, ...Gynecologic Oncology 166, S9, 2022202
4
2022
Real-world clinical outcomes in patients with local/regional HER2-low breast cancer: An NCDB analysis.
C Jiang, S Perimbeti, L Deng, Q Wang, S Gandhi, CL ShapiroJournal of Clinical Oncology 40 (16_suppl), 558-558, 2022202
3
2022
UACA locus is associated with breast cancer chemoresistance and survival
Q Zhu, E Schultz, J Long, JM Roh, E Valice, CA Laurent, KH Radimer, ...NPJ breast cancer 8 (1), 9, 2022202
3
2022
Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis
Clinical outcomes of de novo metastatic HER-low breast cancer: a National Cancer Database AnalysisC Jiang, S Perimbeti, L Deng, CL Shapiro, S GandhiNPJ Breast Cancer 8 (1), 135, 0
2
2022
Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience
S Alaklabi, AM Roy, K Attwood, A George, T O’Connor, A Early, EG Levine, ...Frontiers in Oncology 1, 101391, 0
2
2022
Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer
R Wu, S Gandhi, Y Tokumaru, M Asaoka, M Oshi, L Yan, T Ishikawa, ...Breast Cancer Research and Treatment 95 (), 7-3, 2022202
1
2022
Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting
T Khoury, S Aljabab, S Yao, C Ambrosone, A Omilian, K Attwood, W Ji, ...Breast Cancer Research and Treatment 94 (3), 53-540, 2022202
1
2022
Abstract CT145: Systemic rintatolimod and interferon-α2b selectively reprogram local tumor microenvironment in patients with metastatic triple negative breast cancer for …
Abstract CT45: Systemic rintatolimod and interferon-α2b selectively reprogram local tumor microenvironment in patients with metastatic triple negative breast cancer for …S Gandhi, M Opyrchal, M Grimm, R Slomba, K Kokolus, S Battaglia, ...Cancer Research 82 (2_Supplement), CT45-CT45, 2022202
1
2022
Establishment of a novel BRCAness score that predicts response to PARP inhibitors.
M Oshi, S Gandhi, R Wu, M Asaoka, L Yan, A Yamada, K Narui, ...Journal of Clinical Oncology 40 (6_suppl), 549-549, 2022202
1
2022
Does race influence long-term outcomes after neoadjuvant chemotherapy in breast cancer: A National Cancer Database analysis.
AM Roy, C Jiang, S Yao, S Perimbeti, S GandhiJournal of Clinical Oncology 40 (6_suppl), 606-606, 2022202
1
2022
Pan-cancer characterization of intratumoral autonomic innervation in 32 cancer types in the cancer genome atlas
JF Zhang, H Sheng, J Chen, H Mohammadpour, SJ Ma, MK Farrugia, ...Cancers 4 (0), 254, 2022202
1
2022

Referred From: https://scholar.google.com/citations?hl=en&user=EUauIBcAAAAJ

Cited by
Citations 636
h-index 14
i10-index 17
Recommended Journals
Open Access Journals